Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 21
Filtrar
1.
Biol Pharm Bull ; 41(10): 1567-1573, 2018 Oct 01.
Artigo em Inglês | MEDLINE | ID: mdl-30012927

RESUMO

We evaluated the suitability of Nagoya Shibata Yasuda (NSY) mice as an animal model for examining the influence of a glucose metabolism disorder on bone integrity, using Institute of Cancer Research (ICR) mice as controls. We selected six NSY and ICR mice each that were matched for weight, and measured serum glucose levels, serum insulin levels, and conducted an oral glucose tolerance test. Histological sections of the femurs of both mouse lines were prepared, and the bone strength, mass, and microstructure of the femur were compared, along with bone metabolism. Serum glucose levels were significantly higher in the NSY mice than in the control mice, but body weight and serum insulin levels did not differ between the groups. Bone mass, microstructure, and strength of the femur, and bone metabolism were lower in the NSY mice than in the control mice. In the cortical bone of the femur in the NSY mice, several parts were not stained with eosin, demonstrating a strong negative correlation between serum glucose levels and bone mineral density; however, there was a negative correlation between serum glucose levels and bone metabolic markers. The bone turnover rate in the NSY mice was decreased by hyperglycemia, resulting in a thinner and shorter femur, reduced cortical and trabecular areas, and lower bone mass compared to those of the control mice. Collectively, these results suggest deteriorated bone strength of the femur in NSY mice, serving as a useful model for studying the link between glucose metabolism and bone integrity.


Assuntos
Glicemia/metabolismo , Densidade Óssea/fisiologia , Diabetes Mellitus Tipo 2/genética , Diabetes Mellitus Tipo 2/metabolismo , Modelos Animais de Doenças , Animais , Glicemia/genética , Diabetes Mellitus Tipo 2/patologia , Fêmur/metabolismo , Fêmur/patologia , Masculino , Camundongos , Camundongos Endogâmicos ICR , Camundongos Transgênicos
2.
Calcif Tissue Int ; 101(6): 631-640, 2017 12.
Artigo em Inglês | MEDLINE | ID: mdl-28779183

RESUMO

Although it has been recently shown that type 2 diabetics have an increased risk of hip fracture, the effects of exercise therapy to prevent this have not been clarified. We examined whether a treadmill running exercise contributes to the bone mineral density (BMD) and bone microarchitecture of the femur and what kind of exercise intensity and duration are optimum in type 2 diabetes mellitus using KK-Ay diabetic mice. The mice were divided into two running groups, one fast speed and short duration (FS), the other slow speed and long duration (SL), and a group of controls with no running (CO). The running exercise was started when the mice were 8 weeks of age, and continued once a day 5 days per week for 10 weeks. Ten weeks after the start of the running exercise, the BMD of the proximal region and mid-diaphysis in the SL were significantly higher in comparison with that in the CO, whereas there was no difference in bone microarchitecture among the three groups. Blood glucose, insulin levels, and visceral fat contents in the SL were significantly lower than those in the CO and FS. Bone resorption protein and C-reactive protein levels in the SL were significantly lower than those in the CO. These results suggest that slow, long duration loading is better for both bone and glycemic control than fast, short duration loading in type 2 diabetes.


Assuntos
Densidade Óssea/fisiologia , Diabetes Mellitus Experimental/patologia , Diabetes Mellitus Tipo 2/patologia , Fêmur/patologia , Condicionamento Físico Animal/métodos , Animais , Masculino , Camundongos
3.
Biol Pharm Bull ; 35(3): 438-43, 2012.
Artigo em Inglês | MEDLINE | ID: mdl-22382334

RESUMO

We examined the bone mineral density (BMD) of the proximal region and the mid-diaphysis of the femur using dual energy X-ray absorption (DXA), the blood osteocalcin level and the blood glucose level every five weeks from 8 to 23 weeks old in KK-Ay diabetic mice. The BMD of the proximal region after 18 weeks old was significantly lower when compared with that at 8 weeks old (p<0.05), whereas there was no significant difference in the BMD of the mid-diaphysis at each week. The BMD of the proximal region at 18 weeks old was significantly lower than that in ddY mice, used as controls (p<0.05). The blood osteocalcin level at 18 weeks old was significantly lower than that at 8 weeks old and that in 18-week-old ddY mice (p<0.05). There was significant negative correlation between the blood glucose level and the BMD of the proximal region (r=-0.64, p<0.05). These results suggest that type 2 diabetes exerts an influence only on spongy bone, not on cortical bone, and that the BMD in the proximal region of the femur seems to be affected by blood glucose level, parallel with the progression of diabetes, through the blood osteocalcin level. In the present study, we show the characteristics of diabetic osteopenia in KK-Ay mice, an animal model of type 2 diabetes.


Assuntos
Densidade Óssea , Doenças Ósseas Metabólicas/fisiopatologia , Diabetes Mellitus Tipo 2/fisiopatologia , Animais , Glicemia/análise , Doenças Ósseas Metabólicas/sangue , Doenças Ósseas Metabólicas/etiologia , Diabetes Mellitus Tipo 2/sangue , Diabetes Mellitus Tipo 2/complicações , Modelos Animais de Doenças , Fêmur/fisiopatologia , Masculino , Camundongos
4.
Artigo em Inglês | MEDLINE | ID: mdl-23082086

RESUMO

Banaba (Lagerstroemia speciosa L.) extracts have been used for many years in folk medicine to treat diabetes, with the first published research study being reported in 1940. This paper summarizes the current literature regarding Banaba and its constituents. The hypoglycemic effects of Banaba have been attributed to both corosolic acid as well as ellagitannins. Studies have been conducted in various animal models, human subjects, and in vitro systems using water soluble Banaba leaf extracts, corosolic acid, and ellagitannins. Corosolic acid has been reported to decrease blood sugar levels within 60 min in human subjects. Corosolic acid also exhibits antihyperlipidemic and antioxidant activities. The beneficial effects of Banaba and corosolic acid with respect to various aspects of glucose and lipid metabolism appear to involve multiple mechanisms, including enhanced cellular uptake of glucose, impaired hydrolysis of sucrose and starches, decreased gluconeogenesis, and the regulation of lipid metabolism. These effects may be mediated by PPAR and other signal transduction factors. Banaba extract, corosolic acid, and other constituents may be beneficial in addressing the symptoms associated with metabolic syndrome, as well as offering other health benefits.

5.
J Nutr Sci Vitaminol (Tokyo) ; 67(4): 243-248, 2021.
Artigo em Inglês | MEDLINE | ID: mdl-34470999

RESUMO

Daily fat and sugar intake has increased in Japan, while total energy intake has decreased. However, the number of type 2 diabetes mellitus patients has increased, and this often causes renal injury characterized by autophagic vacuoles. Although many studies with comparisons of high fat or sugar versus a normal macronutrient balanced diet have been reported, there are few studies that equalized calorie intake and body weights. In the current study, AIN93M diets (CONT group) with matching energy content with lard derived high saturated fat (LARD group), soybean oil derived unsaturated fat (SOY OIL group) and sucrose (SUCROSE group) were provided to compare their effects on renal morphology in streptozotocin-injected CD-1 mice without causing obesity. The number of renal tubular vacuoles was higher in SUCROSE and slightly higher in LARD compared with CONT mice, and was higher in LARD and SUCROSE compared with SOY OIL mice. Most of those vacuoles were LAMP1-positive, a marker of lysosomal autophagy. These results suggest that despite identical energy contents, diets with high sucrose or saturated fat compared to unsaturated fat may aggravate lysosomal renal injury in a non-obese, streptozotocin-induced model of diabetes mellitus.


Assuntos
Diabetes Mellitus Tipo 2 , Sacarose , Animais , Dieta , Gorduras na Dieta , Humanos , Rim , Lisossomos , Camundongos , Estreptozocina , Sacarose/efeitos adversos
6.
J Nutr Sci Vitaminol (Tokyo) ; 66(2): 114-118, 2020.
Artigo em Inglês | MEDLINE | ID: mdl-32350172

RESUMO

To decrease body weight and insulin resistance, a calorie-restricted diet-with minimal caloric intake required for daily activities-is the primary treatment strategy for patients with type 2 diabetes (T2D) in Japan. However, many patients cannot continue with this diet for long, because calorie restriction is difficult and nutritional balance is hard to understand. Carbohydrate-restricted diets are easier for patients than conventional calorie-restricted diet. In this study we aimed to elucidate the effects of a moderate carbohydrate-restricted diet on glucose metabolism and renal function in patients with T2D on dipeptidyl peptidase-4 (DPP-4) inhibitors. Nineteen outpatients with T2D continued on a moderate carbohydrate-restricted diet (targeting 50% of calories) for 6 mo. Meanwhile, 10 other outpatients with T2D on DPP-4 inhibitors had the conventional calorie-restricted diet using the food exchange table. No change in prescription drugs occurred for both groups during the study period. After the intervention, the carbohydrate content in dietary intake was lowered significantly from 56.8±8.3 to 46.8±10.1%, while the lipid concentration, primarily n-6 polyunsaturated fatty acids, was significantly increased. There was no significant change in protein intake. Hemoglobin A1c (HbA1c) fell from 7.22±0.74% to 6.95±0.72% (mean±SD). Furthermore, salt intake decreased significantly from 6.8±2.5 g prior to the intervention, to 5.7±1.9 g after the intervention. The estimated glomerular filtration rates (eGFR) decreased slightly, while serum creatinine levels did not change. These findings suggest that a moderate carbohydrate-restricted diet (50%) is effective in patients with T2D, without affecting kidney function.


Assuntos
Glicemia/metabolismo , Diabetes Mellitus Tipo 2/dietoterapia , Dieta com Restrição de Carboidratos , Carboidratos da Dieta/administração & dosagem , Inibidores da Dipeptidil Peptidase IV/uso terapêutico , Hemoglobinas Glicadas/metabolismo , Rim/fisiologia , Idoso , Índice de Massa Corporal , Peso Corporal , Restrição Calórica , Creatinina/sangue , Diabetes Mellitus Tipo 2/sangue , Diabetes Mellitus Tipo 2/tratamento farmacológico , Dieta com Restrição de Carboidratos/efeitos adversos , Ingestão de Energia , Feminino , Taxa de Filtração Glomerular , Humanos , Insulina/sangue , Resistência à Insulina , Japão , Masculino , Pessoa de Meia-Idade , Obesidade/dietoterapia , Redução de Peso
7.
Nutr Cancer ; 60(5): 685-91, 2008.
Artigo em Inglês | MEDLINE | ID: mdl-18791933

RESUMO

A study to evaluate the mechanisms of tumoricidal activity resulting from orally administered extract of Agaricus blazei Murill (A. blazei) was performed in mice bearing syngeneic and xenogeneic tumors. Tumor regression was comparably seen in both syngeneic and xenogeneic tumor-bearing mice when administered oral extract preparations. In addition, in a murine syngeneic tumor model, oral administration of water-soluble extracts of A. blazei resulted in significant production of cytokines such as IFN-gamma, and TNF-alpha in peritoneal exudate cells, in parallel with the marked regression of tumor development. The water-soluble extracts also induced pronounced antioxidant activity in in vitro and in vivo assays using two different methods. These results indicate the A. blazei extract may enhance not only the immnunomodulatory effects that promote activity of peritoneal exudate cells for tumor regression but also potentially result in the direct destruction of tumor cells through its antioxidant activity.


Assuntos
Adjuvantes Imunológicos/farmacologia , Agaricus/imunologia , Antineoplásicos/farmacologia , Antioxidantes/farmacologia , Citotoxicidade Imunológica/efeitos dos fármacos , beta-Glucanas/farmacologia , Animais , Antineoplásicos/imunologia , Citocinas/efeitos dos fármacos , Citocinas/metabolismo , Citotoxicidade Imunológica/imunologia , Modelos Animais de Doenças , Ensaio de Imunoadsorção Enzimática , Sequestradores de Radicais Livres/imunologia , Sequestradores de Radicais Livres/farmacologia , Camundongos , Camundongos Endogâmicos ICR , Fatores de Tempo , beta-Glucanas/imunologia
8.
Auton Neurosci ; 138(1-2): 31-40, 2008 Feb 29.
Artigo em Inglês | MEDLINE | ID: mdl-17936693

RESUMO

Long-term diabetic patients exhibit major clinical gastrointestinal problems, such as diarrhea and constipation. In recent years, water channel protein, aquaporin 1 (AQP1) has been identified in the enteric nervous system (ENS). We have examined the pathological changes in AQP1 immunoreactive (IR) neurons in streptozotocin-induced (STZ) diabetic rats. Eight-week-old Wistar rats were injected with streptozotocin, and artificial diabetes was induced. Sixteen-week-old STZ rats were then examined with double immunofluorescence staining and ABC immunohistochemical staining. AQP1-IR neurons in STZ rats were significantly increased compared with control rats (p<0.01). The ratio of AQP1 vs. HuC/D in STZ rats was also clearly increased as compared with control rats (p<0.05). It was apparent that thick AQP1-IR fibers were frequently observed in the secondary and tertiary myenteric plexus of STZ rats. The AQP1-IR fibers of STZ rats conspicuously showed many swollen varicosities. These swollen varicose fibers were also observed in the longitudinal and circular muscle layers. Streptozotocin-induced diabetic rats showed pathological changes in AQP1-IR neurons of the ENS. The alteration of AQP1-IR neurons may be possible contribute to diabetic gastrointestinal dysfunction in streptozotocin-induced diabetic rats.


Assuntos
Aquaporina 1/metabolismo , Complicações do Diabetes/patologia , Diabetes Mellitus Experimental/complicações , Sistema Nervoso Entérico/patologia , Gastroenteropatias/patologia , Neurônios/patologia , Animais , Axônios/metabolismo , Axônios/patologia , Contagem de Células , Complicações do Diabetes/metabolismo , Complicações do Diabetes/fisiopatologia , Sistema Nervoso Entérico/metabolismo , Sistema Nervoso Entérico/fisiopatologia , Imunofluorescência , Gastroenteropatias/metabolismo , Gastroenteropatias/fisiopatologia , Imuno-Histoquímica , Intestino Delgado/inervação , Intestino Delgado/fisiopatologia , Masculino , Músculo Liso/inervação , Plexo Mientérico/metabolismo , Plexo Mientérico/patologia , Plexo Mientérico/fisiopatologia , Neurônios/metabolismo , Ratos , Ratos Wistar , Regulação para Cima/fisiologia
9.
J Nutr Sci Vitaminol (Tokyo) ; 54(3): 266-8, 2008 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-18635916

RESUMO

The banaba leaf (Lagerstroemia speciosa L.) has been used in traditional Oriental medicine to treat diabetes in the Philippines. It contains corosolic acid (CA), a compound which has a hypoglycemic effect. We examined the effect of CA on blood glucose levels and the hydrolysis of disaccharides in the small intestine in mice. CA (10 mg/kg body weight) improved hyperglycemia after an oral administration of sucrose, and significantly reduced the hydrolysis of sucrose in the small intestine. These results suggest that the hypoglycemic activity of CA is derived, at least in part, due to the inhibition of the hydrolysis of sucrose.


Assuntos
Diabetes Mellitus Tipo 1/metabolismo , Dissacarídeos/metabolismo , Hipoglicemiantes/farmacologia , Fitoterapia/métodos , Sacarose/metabolismo , Triterpenos/farmacologia , Animais , Glicemia/efeitos dos fármacos , Diabetes Mellitus Tipo 1/tratamento farmacológico , Modelos Animais de Doenças , Hidrólise/efeitos dos fármacos , Hiperglicemia/prevenção & controle , Intestino Delgado/efeitos dos fármacos , Intestino Delgado/metabolismo , Lactose/metabolismo , Lagerstroemia , Masculino , Maltose/metabolismo , Medicina Tradicional do Leste Asiático , Camundongos , Camundongos Obesos , Fatores de Tempo , Triterpenos/administração & dosagem
10.
Bone Rep ; 9: 74-83, 2018 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-30094297

RESUMO

OBJECTIVE: Type 2 diabetes mellitus (T2DM) is a metabolic disease characterized by hyperglycemia, hyperinsulinemia, and complications such as obesity and osteoporosis. The Tsumura, Suzuki, Obese Diabetes (TSOD) mouse is an animal model of spontaneous obese T2DM. However, bone metabolism in TSOD mice is yet to be investigated. The objective of the present study was to investigate the effects of T2DM on bone mass, metabolism, microstructure, and strength in TSOD mice. METHODS: We determined the following parameters in TSOD mice and Tsumura, Suzuki, Non-obesity (TSNO) mice (as controls): serum glucose levels; serum insulin levels; bone mass; bone microstructure; bone metabolic markers; and bone strength. We also performed the oral glucose tolerance test and examined histological sections of the femur. We compared these data between both groups at pre-diabetic (10 weeks) and established (20 weeks) diabetic conditions. RESULTS: Bone strength, such as extrinsic mechanical properties, increased with age in the TSOD mice and intrinsic material properties decreased at both 10 weeks and 20 weeks. Bone resorption marker levels in TSOD mice were significantly higher than those in the control mice at both ages, but there was no significant difference in bone formation markers between the groups. Bone mass in TSOD mice was lower than that in controls at both ages. The trabecular bone volume at the femoral greater trochanter increased with age in the TSOD mice. The femoral mid-diaphysis in TSOD mice was more slender and thicker than that in TSNO mice at both ages. CONCLUSIONS: Bone mass of the femur was lower in TSOD mice than in TSNO mice because hyperinsulinemia during pre-diabetic and established diabetic conditions enhanced bone resorption due to high bone turnover. In addition, our data suggest that the bone mass of the femur was significantly reduced as a result of chronic hyperglycemia during established diabetic conditions in TSOD mice. We suggest that bone strength in the femur deteriorated due to the reduction of bone mass and because the femoral mid-diaphysis was more slender in TSOD mice.

11.
J Tradit Chin Med ; 27(3): 212-9, 2007 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-17955661

RESUMO

In this research, Lysolecithin - a substance made with 100% natural ingredients - was given to ICR mice as medication to measure its periodic effect on the noradrenalin (NA), dopamine (DA), and serotonin (5-HT) levels of the brain. Both ICR and SAM mice were separated into two groups - control group and Lysolecithin (K. Lysolecithin: hydrolytic lysolecithin) medicated group, and given 1-week preparation period. The K. Lysolecithin group was given 500 mg/kg of K. Lysolecithin at 0.2 mL per dosage for 4 weeks, and the control group was given the same amount of dosage of water during the same period. NA, DA and 5-HT concentrations were measured from the blood before medication and 8 weeks/12 weeks/16 weeks after the first medication. For the SAM mice, 8 weeks after they were medicated with K .Lysolecithin, Morris Water Maze Test was conducted for 7 consecutive days and then the concentrations were measured by drawing blood from the heart. The K. Lysolecithin medicated group showed a tendency to have a statistically significant higher concentrations of 5-HT and NA in the blood. Also, periodic examination showed that the monoamine levels were highest in the 12th week and declined thereafter.


Assuntos
Doença de Alzheimer/tratamento farmacológico , Monoaminas Biogênicas/sangue , Lisofosfatidilcolinas/administração & dosagem , Doença de Alzheimer/sangue , Animais , Modelos Animais de Doenças , Humanos , Masculino , Camundongos , Camundongos Endogâmicos ICR , Camundongos Transgênicos , Distribuição Aleatória
12.
Pain ; 44(3): 235-239, 1991 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-2052391

RESUMO

Deep pain thresholds of the tender points in man were measured by pulse algometry. In this technique an insulated acupuncture needle (180 microns in diameter, about 400 k omega at 1 kHz) was used as a cathodal monopolar stimulating electrode. The stimulus consisted of a short train (three 1 msec duration pulses at 500 Hz) repeated at 2 Hz, and the current intensity was increased at a constant rate by a command voltage supplied to the stimulator. The stimulus current was monitored on an oscilloscope, and the integrated current was recorded simultaneously on a chart recorder. The tender points were detected by careful palpation, a pressure algometer being used to quantify threshold intensities. The needle electrode was inserted into the same points and deep pain thresholds were measured every 1-2 mm in depth. The deep pain thresholds at the depth where the experimenter felt some stiffness against the needle insertion (what we have termed needling stiffness) were 0.9 +/- 0.1 mA (mean +/- S.E.M., n = 14). Threshold values determined by repetitive measurements at the same position at intervals of 5 min for 6 successive trials were very similar. The stimulus evoked sensation was a dull-heavy deep pain. The pain thresholds changed markedly as the depth of the electrode tip was changed by 1-2 mm (P less than 0.01, t test). The minimum pain threshold under the tender point occurred at the depth of the needling stiffness. Observations with an ultrasonic image scanner suggested that the needle tip was located on or near the fascia when the experimenter felt the needling stiffness.(ABSTRACT TRUNCATED AT 250 WORDS)


Assuntos
Pontos de Acupuntura , Medição da Dor/instrumentação , Adolescente , Adulto , Estimulação Elétrica , Eletrodos , Humanos , Pessoa de Meia-Idade , Pulso Arterial , Limiar Sensorial/fisiologia
13.
Am J Chin Med ; 30(1): 81-6, 2002.
Artigo em Inglês | MEDLINE | ID: mdl-12067100

RESUMO

In the past, nitobegiku (the herb of Tithonia diversifolia (Hemsl) A. Gray) has been used as a medicinal plant for diabetes. Antidiabetic effect of the water extract of Nitobegiku (NG) was investigated in KK-Ay-mice--one of the animal models of type 2 diabetes. NG (1,500 mg/kg body weight) reduced the blood glucose of KK-Ay mice from 509 +/- 22 mg/dl to 340 +/- 14 mg/dl (p < 0.001) and also lowered the plasma insulin (p < 0.05) 7 hours after single oral administration. No change in blood glucose of NG-treated normal mice (ddY) was seen. These results support that NG improve glucose metabolism by reducing insulin resistance. Therefore, NG may be useful for treatment of type 2 diabetes.


Assuntos
Diabetes Mellitus Tipo 2/genética , Medicamentos de Ervas Chinesas/farmacologia , Hipoglicemiantes/farmacologia , Animais , Glicemia/metabolismo , Teste de Tolerância a Glucose , Insulina/sangue , Masculino , Camundongos
14.
Biomed Res ; 31(4): 213-8, 2010 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-20834178

RESUMO

Corosolic acid (CA), contained in the leaves of the banaba plant (Lagerstroemia speciosa L.), is a pentacyclic triterpene, and has hypoglycemic effects. The effects of CA on dietary hypercholesterolemia and hepatic steatosis were assessed in KK-Ay mice, an animal model of type 2 diabetes. Two kinds of high cholesterol diet with or without 0.023% CA, were prepared for the study. KK-Ay mice were fed a normal diet (controls), the high cholesterol diet with CA (CA-mice) or that without CA (HC-mice) for 10 weeks. CA inhibited the mean blood cholesterol level by 32% (P<0.05) and the liver cholesterol content by 46% (P<0.05) compared with those of HC-mice 10 weeks after the start of dietary intake. Acutely, CA inhibited the mean blood cholesterol level 4 h after the administration of a high-cholesterol cocktail in an oral cholesterol-loading test, compared with that of control mice (P<0.05). These results suggest that CA has some direct effects on the cholesterol absorption process in the small intestine. CA may inhibit the activity of cholesterol acyltransferase, which acts in the re-esterification of cholesterol in the small intestine, in type 2 diabetes.


Assuntos
Colesterol na Dieta/efeitos adversos , Fígado Gorduroso/tratamento farmacológico , Hipercolesterolemia/tratamento farmacológico , Hipoglicemiantes/farmacologia , Triterpenos/farmacologia , Animais , Glicemia/efeitos dos fármacos , Glicemia/metabolismo , Colesterol/sangue , Diabetes Mellitus Tipo 2/tratamento farmacológico , Diabetes Mellitus Tipo 2/metabolismo , Modelos Animais de Doenças , Inibidores Enzimáticos/farmacologia , Hipoglicemiantes/isolamento & purificação , Insulina/sangue , Lagerstroemia/química , Masculino , Camundongos , Camundongos Endogâmicos , Extratos Vegetais/farmacologia , Folhas de Planta/química , Plantas Medicinais/química , Esterol O-Aciltransferase/efeitos dos fármacos , Esterol O-Aciltransferase/metabolismo
15.
Biol Pharm Bull ; 31(4): 651-5, 2008 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-18379057

RESUMO

Corosolic acid (CRA), a constituent of Banaba leaves, has been reported to exert anti-hypertension, anti-hyperinsulinemia, anti-hyperglycemia, and anti-hyperlipidemia effects as well as to induce anti-inflammatory and anti-oxidative activities. The aim of this study was to investigate the inhibitory effects of CRA on the development of obesity and hepatic steatosis in KK-Ay mice, a genetically obese mouse model. Six-week-old KK-Ay mice were fed a high fat diet for 9 weeks with or without 0.023% CRA. Nine-week CRA treatment resulted in 10% lower body weight and 15% lower total fat (visceral plus subcutaneous fat) mass than in control mice. CRA treatment reduced fasting plasma levels of glucose, insulin, and triglyceride by 23%, 41%, and 22%, respectively. The improved insulin sensitivity in CRA-treated mice may be due on part to the increased plasma adiponectin and white adipose tissue (WAT) AdipoR1 levels. In addition, CRA treatment increased the expression of peroxisome proliferator-activated receptor (PPAR) alpha in liver and PPAR gamma in WAT. This is the first study to show that CRA treatment can contribute to reduced body weight and amelioration of hepatic steatosis in mice fed a high fat diet, due in part to increased expression of PPAR alpha in liver and PPAR gamma in WAT.


Assuntos
Fármacos Antiobesidade , Doença Hepática Induzida por Substâncias e Drogas/tratamento farmacológico , Inibidores Enzimáticos/farmacologia , Obesidade/tratamento farmacológico , Triterpenos/farmacologia , Adiponectina/biossíntese , Tecido Adiposo/patologia , Tecido Adiposo Branco/efeitos dos fármacos , Tecido Adiposo Branco/metabolismo , Animais , Glicemia/metabolismo , Composição Corporal/efeitos dos fármacos , Peso Corporal/efeitos dos fármacos , Doença Hepática Induzida por Substâncias e Drogas/patologia , Dieta , Ácidos Graxos/metabolismo , Fígado/patologia , Masculino , Camundongos , Obesidade/patologia , Oxirredução , PPAR alfa/antagonistas & inibidores , PPAR alfa/biossíntese , Receptores de Adiponectina/biossíntese , Receptores de Adiponectina/genética , Reação em Cadeia da Polimerase Via Transcriptase Reversa , Triglicerídeos/biossíntese
16.
J Physiol Anthropol ; 26(2): 143-8, 2007 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-17435357

RESUMO

This study investigated the relationship between the force applied to a finger and the differential threshold of the force. Further, it presented an improvement function for tactile perception in archers by adapting to circumstances in which enhanced tactile perception and finger dexterity are required to practice archery on a daily basis. For this purpose, a tactile display using an air jet was developed. The air was aimed at the center of the fingertip of the index finger. The inner diameter of the nozzle was set to 3 mm. In this study, a psychophysical experiment was conducted to obtain the differential threshold from two subject groups-an archery athlete group and a control group. A total of six levels of standard stimuli ranging from 2.0 gf to 7.0 gf was obtained. As a result, the differential threshold of the archery group was significantly higher than that of the control group. The Weber ratio of the archery group remained around 0.13 and that of control group was 0.10. The experiment also revealed that the differential threshold for archers exhibited less fluctuation between the trials and between the days, which implied that the tactile perception of archery athletes may be more stable than that of non-experienced subjects. This may be a plasticity property of tactile perception.


Assuntos
Adaptação Fisiológica , Dedos/fisiologia , Esportes , Tato/fisiologia , Adulto , Fenômenos Biomecânicos , Estudos de Casos e Controles , Humanos , Masculino , Limiar Sensorial , Vibração
17.
Biol Pharm Bull ; 29(3): 585-7, 2006 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-16508174

RESUMO

The antidiabetic effects of corosolic acid (CA) were investigated in KK-Ay mice, an animal model of type 2 diabetes. CA (2 mg/kg body weight) reduced the blood glucose levels of KK-Ay mice 4 h after a single oral dose. CA (2 mg/kg) reduced the blood glucose levels in KK-Ay mice 2 weeks after a single oral dose and also significantly lowered plasma insulin levels were in KK-Ay mice under similar conditions. CA-treated KK-Ay mouse blood glucose significantly decreased in an insulin tolerance test. These results support the hypothesis that CA improves glucose metabolism by reducing insulin resistance. Therefore CA may be useful for the treatment of type 2 diabetes.


Assuntos
Diabetes Mellitus Tipo 2/tratamento farmacológico , Inibidores Enzimáticos/farmacologia , Hipoglicemiantes , Triterpenos/farmacologia , Animais , Glicemia/metabolismo , Diabetes Mellitus Tipo 2/genética , Teste de Tolerância a Glucose , Insulina/sangue , Masculino , Camundongos
18.
Biol Pharm Bull ; 28(11): 2152-4, 2005 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-16272709

RESUMO

Nitobegiku (the herb of Tithonia diversifolia (HEMSL) A. GRAY) has been used as a medicinal plant for diabetes. The antidiabetic effect of an 80% ethanol extract of Nitobegiku (Td) was investigated in KK-Ay-mice, an animal model of type 2 diabetes. Td (500 mg/kg body weight) reduced the blood glucose of KK-Ay mice 7 h after a single oral dose. No change in blood glucose in Td-treated normal mice (ddY) was seen. Td (500 mg/kg) reduced blood glucose in KK-Ay mice 3 weeks after a single oral dose and also significantly lowered plasma insulin in KK-Ay mice under similar conditions. Td-treated KK-Ay mouse blood glucose was significantly decreased in an insulin tolerance test. These results support the hypothesis that Td improves glucose metabolism by reducing insulin resistance. Therefore, Nitobegiku may be useful for the treatment of type 2 diabetes.


Assuntos
Chrysanthemum/química , Diabetes Mellitus Tipo 2/tratamento farmacológico , Medicamentos de Ervas Chinesas/farmacologia , Hipoglicemiantes/farmacologia , Animais , Glicemia/metabolismo , Diabetes Mellitus Tipo 2/genética , Relação Dose-Resposta a Droga , Teste de Tolerância a Glucose , Insulina/sangue , Masculino , Camundongos , Camundongos Endogâmicos
19.
Biol Pharm Bull ; 27(2): 248-50, 2004 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-14758046

RESUMO

The antidiabetic activity of Momordica charantia L. (Cucurbitaceae) with exercise was investigated in KK-Ay mice, an animal model with type 2 diabetes with hyperinsulinemia. The water extract of the fruit of Momordica charantia L. (MC) with exercise reduced the blood glucose of KK-Ay mice 5 weeks after oral administration (p<0.001), and also significantly lowered the plasma insulin of KK-Ay mice under similar conditions (p<0.01). The blood glucose of MC with exercise is lower than that of MC only or exercise only 5 weeks after the administration. MC with exercise decreased blood glucose in a glucose tolerance test. These results suggest that MC with exercise is useful for type 2 diabetic cure.


Assuntos
Glicemia/efeitos dos fármacos , Diabetes Mellitus Tipo 2/terapia , Hipoglicemiantes/uso terapêutico , Momordica charantia/química , Fitoterapia , Administração Oral , Animais , Peso Corporal , Diabetes Mellitus Tipo 2/sangue , Diabetes Mellitus Tipo 2/tratamento farmacológico , Frutas/química , Teste de Tolerância a Glucose , Insulina/sangue , Camundongos , Condicionamento Físico Animal , Preparações de Plantas/uso terapêutico , Fatores de Tempo
20.
Biol Pharm Bull ; 27(7): 1103-5, 2004 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-15256748

RESUMO

The effect of corosolic acid (CA) on blood glucose was studied in KK-Ay mice, an animal model of type 2 diabetes. CA (10 mg/kg) reduced the blood glucose (p<0.05) of KK-Ay mice 4 h after single oral administration when compared with the control group. However, CA did not change the plasma insulin. The muscle facilitative glucose transporter isoform 4 (GLUT4) translocation from low-density microsomal membrane to plasma membrane was significantly increased in the orally CA-treated mice when compared with that of the controls (p<0.05). These results suggest that the hypoglycemic effect of CA is derived, at least in part, from an increase in GLUT4 translocation in muscle. Therefore, it may be that CA has beneficial effects on hyperglycemia in type 2 diabetes.


Assuntos
Diabetes Mellitus Tipo 2/sangue , Diabetes Mellitus Tipo 2/genética , Proteínas de Transporte de Monossacarídeos/genética , Proteínas de Transporte de Monossacarídeos/metabolismo , Proteínas Musculares/genética , Proteínas Musculares/metabolismo , Triterpenos/farmacologia , Animais , Glicemia/efeitos dos fármacos , Glicemia/metabolismo , Diabetes Mellitus Tipo 2/tratamento farmacológico , Modelos Animais de Doenças , Transportador de Glucose Tipo 4 , Insulina/sangue , Masculino , Camundongos , Triterpenos/uso terapêutico
SELEÇÃO DE REFERÊNCIAS
Detalhe da pesquisa